ATE242263T1 - Estra-5(10),7-diene mit östrogener aktivität - Google Patents

Estra-5(10),7-diene mit östrogener aktivität

Info

Publication number
ATE242263T1
ATE242263T1 AT98915224T AT98915224T ATE242263T1 AT E242263 T1 ATE242263 T1 AT E242263T1 AT 98915224 T AT98915224 T AT 98915224T AT 98915224 T AT98915224 T AT 98915224T AT E242263 T1 ATE242263 T1 AT E242263T1
Authority
AT
Austria
Prior art keywords
estra
diene
estrogenic activity
estrogenic
activity
Prior art date
Application number
AT98915224T
Other languages
English (en)
Inventor
Fangming Kong
Leonard Alexander Mcdonald
Michael Z Kagan
Syed Muzafar Shah
Panolil Raveendranath
Mark Andrew Collins
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE242263T1 publication Critical patent/ATE242263T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98915224T 1997-04-07 1998-04-02 Estra-5(10),7-diene mit östrogener aktivität ATE242263T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83533697A 1997-04-07 1997-04-07
US85057097A 1997-05-02 1997-05-02
PCT/US1998/006461 WO1998045315A1 (en) 1997-04-07 1998-04-02 Estra-5(10),7-dienes with estrogenic activity

Publications (1)

Publication Number Publication Date
ATE242263T1 true ATE242263T1 (de) 2003-06-15

Family

ID=27125779

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98915224T ATE242263T1 (de) 1997-04-07 1998-04-02 Estra-5(10),7-diene mit östrogener aktivität

Country Status (15)

Country Link
EP (1) EP0973790B1 (de)
JP (1) JP2001518896A (de)
KR (1) KR20010006118A (de)
CN (1) CN1259137A (de)
AR (1) AR012341A1 (de)
AT (1) ATE242263T1 (de)
AU (1) AU738486B2 (de)
BR (1) BR9809748A (de)
CA (1) CA2286457A1 (de)
DE (1) DE69815329T2 (de)
DK (1) DK0973790T3 (de)
ES (1) ES2200334T3 (de)
NZ (1) NZ500217A (de)
PT (1) PT973790E (de)
WO (1) WO1998045315A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200301023A1 (ru) * 2001-03-16 2004-02-26 Уайт Заместительная терапия эстрогенами
WO2009120678A2 (en) * 2008-03-24 2009-10-01 Signa Chemistry, Llc Birch reduction of steroid substrates via alkali metal-silica gel materials
AU2013289344A1 (en) 2012-07-10 2015-02-05 Bayer Pharma Aktiengesellschaft 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MA38349A1 (fr) 2013-02-21 2017-02-28 Bayer Pharma AG Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1093360B (de) * 1958-02-17 1960-11-24 Ayerst Mckenna & Harrison Verfahren zur Herstellung von stabilen antioestrogen wirksamen Verbindungen der Oestranreihe
US2930805A (en) * 1959-01-19 1960-03-29 American Home Prod Novel derivatives of estrane
US3340278A (en) * 1965-05-03 1967-09-05 American Home Prod 5(10), 7-estradiene-3, 17-dione and the process for the production thereof
DK0565296T3 (da) * 1992-04-07 1996-12-09 Neurim Pharma 1991 Anvendelse af melatonin til fremstilling af et lægemiddel til behandling af godartet prostatahyperplasi

Also Published As

Publication number Publication date
BR9809748A (pt) 2000-06-20
CA2286457A1 (en) 1998-10-15
ES2200334T3 (es) 2004-03-01
NZ500217A (en) 2001-11-30
DE69815329D1 (de) 2003-07-10
DE69815329T2 (de) 2004-04-29
EP0973790B1 (de) 2003-06-04
AR012341A1 (es) 2000-10-18
CN1259137A (zh) 2000-07-05
PT973790E (pt) 2003-10-31
DK0973790T3 (da) 2003-09-22
JP2001518896A (ja) 2001-10-16
WO1998045315A1 (en) 1998-10-15
EP0973790A1 (de) 2000-01-26
KR20010006118A (ko) 2001-01-26
AU6946298A (en) 1998-10-30
AU738486B2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
CY2325B1 (en) Estrogenic agents.
NO971814L (no) Östrogene midler
DE69723886D1 (de) Dünne,komfortable,interlabiale absorbierende struktur
EP0672430A3 (de) Befeuchtenleitung.
FI953523L (fi) Fenyyli-3-dimetyyliamino-propaaniyhdisteet, joilla on farmakologista vaikutusta
EP0662776A3 (de) Funkzellen-Erweiterung.
DE69528197D1 (de) Neue 1,3-dialkylharnstoff-derivate
ID22228A (id) Turunan-turunan 16-hidroksi-11-(disubstitusifenil)-estra-4,9-diena
ZA989431B (en) D-homo-9,10-secochloldesta-23-yne-3,25-diol derivatives
FI960529L (fi) Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents (b,f)oksepiinit
EP0663426A3 (de) Blends auf der Basis von Copolyarylenethersulfonen.
DE69815329D1 (de) Estra-5(10),7-diene mit östrogener aktivität
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
DK115394A (da) Etgrebsblandingsarmatur
ZA9510923B (en) 14,17-c2-bridged steroids
TR199500905A2 (tr) Tetrasiklik triterpenler.
DK102394A (da) Étgrebsblandingsarmatur
HK1024923A (en) Estra-5(10), 7-dienes with estrogenic activity
KR960002319U (ko) 개폐밸브구조
TEX RTX--LTX-KS\FEV
ES1029350Y (es) Nueva estructura de asiento.
IT1268116B1 (it) Sedia.
ZA983685B (en) Pregnanes.
TW382191U (en) Improved structure on betel-nut shears
IT235750Y1 (it) Sci.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0973790

Country of ref document: EP

REN Ceased due to non-payment of the annual fee